Sabaa International Company for Pharmaceutical and Chemical Industry
CASE:SIPC Stock Report
Market Cap: ج.م865.0m
Sabaa International Company for Pharmaceutical and Chemical Industry Past Earnings Performance
Past criteria checks 2/6
Sabaa International Company for Pharmaceutical and Chemical Industry's earnings have been declining at an average annual rate of -32.9%, while the Pharmaceuticals industry saw earnings growing at 21.4% annually. Revenues have been declining at an average rate of 13.9% per year. Sabaa International Company for Pharmaceutical and Chemical Industry's return on equity is 9.5%, and it has net margins of 18.4%.
Key information
-32.92%
Earnings growth rate
-29.86%
EPS growth rate
Pharmaceuticals Industry Growth
9.80%
Revenue growth rate
-13.86%
Return on equity
9.55%
Net Margin
18.37%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sabaa International Company for Pharmaceutical and Chemical Industry makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
CASE:SIPC Revenue, expenses and earnings (EGP Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
55
10
9
0
30 Sep 25
54
14
13
0
30 Jun 25
43
5
12
0
31 Mar 25
33
-6
13
0
31 Dec 24
23
-18
13
0
30 Sep 24
16
-10
7
0
30 Jun 24
13
-8
7
0
31 Mar 24
12
-8
6
0
31 Dec 23
13
1
6
0
30 Sep 23
13
-4
6
0
30 Jun 23
17
-4
6
0
31 Mar 23
19
-1
6
0
31 Dec 22
18
0
6
0
30 Sep 22
20
2
7
0
30 Jun 22
25
5
7
0
31 Mar 22
37
4
8
0
31 Dec 21
45
5
10
0
30 Sep 21
61
10
12
0
30 Jun 21
66
12
14
0
31 Mar 21
60
11
18
0
31 Dec 20
70
12
20
0
30 Sep 20
70
13
18
0
30 Jun 20
66
9
19
0
31 Mar 20
71
11
17
0
31 Dec 19
67
9
18
0
30 Sep 19
56
2
18
0
30 Jun 19
56
2
18
0
31 Mar 19
53
2
18
0
31 Dec 18
50
2
16
0
30 Sep 18
56
11
14
0
30 Jun 18
87
15
11
0
31 Mar 18
86
17
8
0
31 Dec 17
84
17
7
0
30 Sep 17
96
11
7
0
30 Jun 17
58
7
7
0
31 Mar 17
52
5
7
0
31 Dec 16
46
5
6
0
30 Sep 16
22
2
6
0
30 Jun 16
20
2
6
0
31 Mar 16
20
3
6
0
31 Dec 15
19
2
6
0
30 Sep 15
17
2
5
0
30 Jun 15
18
3
5
0
Quality Earnings: SIPC has high quality earnings.
Growing Profit Margin: SIPC became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SIPC's earnings have declined by 32.9% per year over the past 5 years.
Accelerating Growth: SIPC has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SIPC has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (31.6%).
Return on Equity
High ROE: SIPC's Return on Equity (9.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/20 11:37
End of Day Share Price
2026/05/20 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sabaa International Company for Pharmaceutical and Chemical Industry is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.